Upregulated Stromal EGFR and Vascular Remodeling in Mouse Xenograft Models of Angiogenesis Inhibitor–resistant Human Lung Adenocarcinoma

Journal of Clinical Investigation - United States
doi 10.1172/jci42405
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Pancreatic Adenocarcinoma Upregulated Factor, a Novel Endothelial Activator, Promotes Angiogenesis and Vascular Permeability

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

A Murine Xenograft Model of Spontaneous Metastases of Human Lung Adenocarcinoma

Journal of Surgical Research
Surgery
2011English

Association of EGFR Expression Level and Cetuximab Activity in Patient-Derived Xenograft Models of Human Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Inhibition of Ornithine Decarboxylase�1 Facilitates Pegylated Arginase Treatment in Lung Adenocarcinoma Xenograft Models

Oncology Reports
MedicineCancer ResearchOncology
2018English

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

Plasticity of Vascular Resident Mesenchymal Stromal Cells During Vascular Remodeling

Vascular Biology
2019English

Mouse Models for Human Lung Cancer

Genes and Development
GeneticsDevelopmental Biology
2005English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy